US Spending on Mental Health and Substance Use Disorders Increased Due to More Individuals Seeking Treatment
In a recent analysis by RTI International, in partnership with the Bureau of Economic Analysis, findings show a significant upsurge in U.S. spending on mental health and substance use disorder treatments. This financial growth, documented from 2000 through 2021, displays an increase from $40.9 billion to $139.6 billion. Impressive statistics demonstrate that a staggering 87% of this escalation is attributed to more individuals engaging in treatment, while the remaining 13% is linked to the rising costs associated with treatment per case.
The comprehensive research, published in the esteemed journal Health Affairs, utilized data from the Bureau of Economic Analysis Health Care Satellite Account. It offers a detailed examination of treatment spending across more than two decades in association with various driving factors. Notably, 5.5% of total medical spending in the U.S. was allocated toward handling mental health and substance use disorders in 2021—a vital insight for both policymakers and health systems aiming to enhance access to mental health care and optimize outcomes.
The lead author of the study, Dr. Tami Mark, a Distinguished Fellow at RTI, elucidates the severe impact mental health and substance use disorders have on the population—emphasizing their notable contribution to premature mortality, as observed in cases of suicide, drug overdoses, and other accidents.
Different categories of disorders exhibited varied growth patterns. Treatment expenditures for mood disorders remained the largest sector of mental health spending in both 2000 and 2021. Since then, anxiety disorders, along with attention-deficit/hyperactivity disorder (ADHD), have notably shown some of the most rapid increases in per capita spending. Conversely, the greatest surge in the number of treated cases appeared within the substance use disorder category.
Several factors are believed to underlie this notable increase in treatment engagement, including shifts in diagnostic criteria, a reduction in societal stigma regarding mental health issues, expanded insurance coverage, and a rise in availability for both medication-based and primary care delivered treatment services.
With these findings, the RTI researchers emphasize the pressing need for improved data systems to trace treatment pathways and relate them to long-term outcomes, such as individual recovery, enhanced functioning, quality of life improvements, and overall well-being.
This study serves as an essential touchpoint for understanding the dynamics of mental health and substance use disorder treatments in the United States, outlining both current spending patterns and implications for future healthcare policies. For those interested in further exploration of this topic, the full study is accessible for review.
Moreover, RTI International remains committed to addressing critical challenges in behavioral health and continues to lead efforts in related research areas. The organization’s dedication to improving human conditions through innovative and objective solutions enhances its reputation as an indispensable resource in the health research landscape.
For additional insights into RTI's contributions towards behavioral health research or substance use studies, interested parties are encouraged to visit their official website for more information.
The comprehensive research, published in the esteemed journal Health Affairs, utilized data from the Bureau of Economic Analysis Health Care Satellite Account. It offers a detailed examination of treatment spending across more than two decades in association with various driving factors. Notably, 5.5% of total medical spending in the U.S. was allocated toward handling mental health and substance use disorders in 2021—a vital insight for both policymakers and health systems aiming to enhance access to mental health care and optimize outcomes.
The lead author of the study, Dr. Tami Mark, a Distinguished Fellow at RTI, elucidates the severe impact mental health and substance use disorders have on the population—emphasizing their notable contribution to premature mortality, as observed in cases of suicide, drug overdoses, and other accidents.
Different categories of disorders exhibited varied growth patterns. Treatment expenditures for mood disorders remained the largest sector of mental health spending in both 2000 and 2021. Since then, anxiety disorders, along with attention-deficit/hyperactivity disorder (ADHD), have notably shown some of the most rapid increases in per capita spending. Conversely, the greatest surge in the number of treated cases appeared within the substance use disorder category.
Several factors are believed to underlie this notable increase in treatment engagement, including shifts in diagnostic criteria, a reduction in societal stigma regarding mental health issues, expanded insurance coverage, and a rise in availability for both medication-based and primary care delivered treatment services.
With these findings, the RTI researchers emphasize the pressing need for improved data systems to trace treatment pathways and relate them to long-term outcomes, such as individual recovery, enhanced functioning, quality of life improvements, and overall well-being.
This study serves as an essential touchpoint for understanding the dynamics of mental health and substance use disorder treatments in the United States, outlining both current spending patterns and implications for future healthcare policies. For those interested in further exploration of this topic, the full study is accessible for review.
Moreover, RTI International remains committed to addressing critical challenges in behavioral health and continues to lead efforts in related research areas. The organization’s dedication to improving human conditions through innovative and objective solutions enhances its reputation as an indispensable resource in the health research landscape.
For additional insights into RTI's contributions towards behavioral health research or substance use studies, interested parties are encouraged to visit their official website for more information.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.